Gwang-Cheol Park
Amministratore Delegato presso Premierbio Co., Ltd.
Posizioni attive di Gwang-Cheol Park
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Amministratore Delegato | - | - |
Storia della carriera di Gwang-Cheol Park
Precedenti posizioni note di Gwang-Cheol Park
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DSK CO., LTD. | Amministratore Delegato | 30/03/2016 | - |
| Presidente | 30/03/2016 | - | |
| HYUNDAI SECURITIES CO LTD | Direttore/Membro del Consiglio | 21/06/2010 | - |
| Independent Dir/Board Member | 21/06/2010 | - |
Formazione di Gwang-Cheol Park
| Konkuk University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Corea del Sud | 5 |
Posizioni
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Finance | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Aziende private | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Gwang-Cheol Park
- Esperienza
